PRVA Privia Health Group, Inc.
Services-Health Services · Nasdaq · SEC CIK 1759655 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY19.2%
TTM net income YoY91.3%
TTM EPS YoY85.7%
Revenue 3-yr CAGR15.5%
Net income 3-yr CAGR-3.0%
Margins
Gross margin—
Operating margin2.1%
Net margin1.4%
FCF margin—
EBITDA margin2.6%
Returns
ROE4.6%
ROA2.4%
ROIC (approx.)10.0%
Asset turnover1.67x
Leverage & solvency
Liabilities / assets44.2%
Debt / equity0.00x
Current ratio1.63x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.11x
Accruals ratio-5.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $656.96M | $632.63M | $603.85M | $541.17M | $580.42M | $521.15M | $480.10M | $460.90M |
| SG&A expense | $34.45M | $39.66M | $41.47M | $29.27M | $39.64M | $37.52M | $31.72M | $34.42M |
| Operating income | $20.54M | $11.77M | $7.42M | $11.28M | $14.40M | $3.34M | $5.22M | $5.25M |
| Pretax income | $22.27M | $16.75M | $9.31M | $13.37M | $16.67M | $5.74M | $8.15M | $8.02M |
| Income tax | $7.67M | $7.02M | $5.60M | $2.79M | $6.87M | $2.46M | $2.10M | $2.65M |
| Net income | $13.49M | $9.05M | $3.06M | $9.15M | $6.86M | $2.69M | $4.22M | $4.40M |
| EBITDA | $24.04M | $15.13M | $10.70M | $13.94M | $17.17M | $5.92M | $7.12M | $7.08M |
| EPS (basic) | 0.11 | 0.07 | 0.02 | — | 0.06 | 0.02 | 0.03 | — |
| EPS (diluted) | 0.10 | 0.07 | 0.02 | — | 0.05 | 0.02 | 0.03 | — |
| Weighted avg. shares (diluted) | 132.71M | 131.83M | 130.88M | — | 128.78M | 128.45M | 127.75M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $446.28M | $412.20M | $419.52M | $479.69M | $441.35M | $390.13M | $469.33M | $491.15M |
| Receivables | $623.58M | $574.16M | $513.68M | $400.90M | $499.04M | $443.99M | $388.73M | $316.18M |
| Current assets | $1.10B | $1.03B | $966.02M | $911.00M | $970.93M | $882.96M | $886.47M | $834.82M |
| PP&E, net | $1.02M | $272,000 | $384,000 | $504,000 | $662,000 | $827,000 | $1.01M | $1.24M |
| Goodwill | $215.79M | $215.79M | $209.84M | $209.84M | $172.22M | $172.22M | $141.62M | $141.62M |
| Intangibles | $215.29M | $218.65M | $212.78M | $215.92M | $167.54M | $170.14M | $108.13M | $109.81M |
| Total assets | $1.56B | $1.49B | $1.42B | $1.37B | $1.35B | $1.27B | $1.18B | $1.14B |
| Current liabilities | $674.36M | $634.44M | $601.30M | $568.52M | $582.91M | $534.85M | $470.81M | $449.15M |
| Total liabilities | $690.80M | $650.51M | $611.99M | $578.43M | $588.23M | $539.00M | $474.01M | $452.34M |
| Shareholders' equity | $815.72M | $782.33M | $753.06M | $737.22M | $709.12M | $682.86M | $659.44M | $635.18M |
| Shares outstanding | 127.77M | 126.29M | 125.69M | 123.60M | 122.87M | 122.67M | 121.39M | 120.31M |
| Cash flow statement | ||||||||
| Operating cash flow | $28.94M | $1.10M | -$49.47M | $127.50M | $51.99M | $7.97M | -$24.06M | $74.80M |
| Investing cash flow | -$1.07M | -$11.46M | -$26,000 | -$91.31M | -$1.20M | -$89.06M | $0 | -$6.26M |
| Financing cash flow | $6.21M | $3.04M | -$10.67M | $2.15M | $431,000 | $1.88M | $2.24M | $619,000 |
| Depreciation & amortization | $3.50M | $3.36M | $3.28M | $2.66M | $2.77M | $2.58M | $1.90M | $1.83M |
| Stock-based compensation | $14.03M | $19.40M | $21.92M | $15.45M | $18.98M | $18.85M | $17.79M | $15.28M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.